N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide(CAS: 2097381-85-4)
![N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide](https://cnstatic.chemtradehub.com/structs/209/2097381-85-4-5b40.webp)
CAS号
相关产品
其他供应商提供的 N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide
基本信息
分子式
C27H33N5O4S
分子量
523.65 g/mol
化学标识符
SMILES
Cc1c(scn1)c2ccc(cc2)CNC(=O)C3CC(CN3C(=O)C(C(C)(C)C)NC(=O)C4(CC4)C#N)O
InChIKey
NDVQUNZCNAMROD-RZUBCFFCSA-N
数据库引用
MDL号
MFCD30742947
常见问题
VH-298为白色或类白色结晶性粉末,分子量约为500。其溶解性较好,易溶于有机溶剂,如乙腈、乙醇,在水中的溶解度较低。VH-298是一种手性化合物,具有一定的反应活性,在合成过程中表现出良好的选择性和较高的产率。
VH-298的合成通常通过手性导向的不对称合成方法实现。该合成过程涉及多个步骤,包括酰胺化、环合、还原等反应。反应过程中使用了多种催化剂,如过渡金属催化剂、手性配体等,以提高反应的选择性和产率。
VH-298作为一种新型手性化合物,主要应用于医药和药物化学领域,用于开发新型药物。此外,由于其特殊的化学结构,它还可能在精细化工、农药等领域有潜在的应用前景。
处理VH-298时应穿戴适当的个人防护装备(PPE),包括实验室外套、手套(乳胶或丁腈)、安全眼镜或面罩。操作应在通风橱内进行,以减少有害气体的暴露。如发生泄露,应立即停止操作,通风,并使用适当的吸收材料清理。参考安全数据表(SDS)以获取更详细的安全指导。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
联系人
Kevin
邮箱
Kevin-NTQY@outlook.com


![Methyl 4-[6-{4-[(methoxycarbonyl)amino]phenyl}-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinecarboxylate](https://cnstatic.chemtradehub.com/structs/106/1062169-56-5-2010.webp)
![2-(Dimethylamino)-1-[2-(3-ethyl-5-methyl-1,2-oxazol-4-yl)-1H-indol-3-yl]ethanol](https://cnstatic.chemtradehub.com/structs/805/80565-58-8-4f25.webp)

![N-{5-[(3R)-3-Hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)[1,3]oxazolo[4,5-b]pyridin-6-yl}-2-(2-methyl-4-pyridinyl)-1,3-oxazole-4-carboxamide](https://cnstatic.chemtradehub.com/structs/180/1801344-14-8-7990.webp)
![6-[4-(1-Isopropyl-4-piperidinyl)-1,4-diazepan-1-yl]-N-(4-pyridinyl)-2-pyridinecarboxamide](https://cnstatic.chemtradehub.com/structs/137/1373268-67-7-3725.webp)
![(6S)-1-(3,4-Difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(trans-4-methoxycyclohexyl)-1H-benzimidazol-2-yl]-2-piperidinone](https://cnstatic.chemtradehub.com/structs/222/2222941-37-7-49be.webp)
![(R)-3-[(E)-[[(S)-1-[2-(Diphenylphosphino)phenyl]ethyl]imino]methyl]-[1,1’-binaphthalene]-2,2’-diol](https://cnstatic.chemtradehub.com/structs/158/1582249-48-6-8775.webp)

![N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide — MedChemExpress LLC](https://cnstatic.chemtradehub.com/suppliers/67ced0fb2b2de6e8e95a67fd/67ced0fb2b2de6e8e95a67fd-logo.webp)
![N-[(1-Cyanocyclopropyl)carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-[4-(4-methyl-1,3-thiazol-5-yl)benzyl]-L-prolinamide — 乐研试剂](https://cnstatic.chemtradehub.com/suppliers/67ce1f8657537e5c8069b370/67ce1f8657537e5c8069b370-logo.webp)